Education
About Us
Working with TipRanks
Follow Us
Onconetix (ONCO)
NASDAQ:ONCO
Total Valuation
Onconetix has a market cap or net worth of $2.25M. The enterprise value is $9.97M.
Market Cap$2.25M
Enterprise Value$9.97M
Share Statistics
Onconetix has 521,863 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding521,863
Owned by Insiders2.94%
Owned by Institutions0.13%
Financial Efficiency
Onconetix’s return on equity (ROE) is -6.11 and return on invested capital (ROIC) is -286.99%.
Return on Equity (ROE)-6.11
Return on Assets (ROA)-2.08
Return on Invested Capital (ROIC)-286.99%
Return on Capital Employed (ROCE)-5.71
Revenue Per Employee210.34K
Profits Per Employee-4.89M
Employee Count12
Asset Turnover0.09
Inventory Turnover22.93
Valuation Ratios
The current PE Ratio of Onconetix is -0.03. Onconetix’s PEG ratio is <0.01.
PE Ratio-0.03
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value0.18
Price to FCF-0.34
Price to Operating Cash Flow>-0.01
PEG Ratio<0.01
Income Statement
In the last 12 months, Onconetix had revenue of 2.52M and earned -58.69M in profits. Earnings per share was -1.82K.
Revenue2.52M
Gross Profit1.06M
Operating Income-56.49M
Pretax Income-59.74M
Net Income-58.69M
EBITDA-57.60M
Earnings Per Share (EPS)-1.82K
Cash Flow
In the last 12 months, operating cash flow was -7.26M and capital expenditures -23.89K, giving a free cash flow of -7.29M billion.
Operating Cash Flow-7.26M
Free Cash Flow-7.29M
Free Cash Flow per Share-13.96
Dividends & Yields
Onconetix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.34
52-Week Price Change-99.05%
50-Day Moving Average5.83
200-Day Moving Average92.88
Relative Strength Index (RSI)45.56
Average Volume (3m)178.06K
Important Dates
Onconetix upcoming earnings date is May 10, 2024, After Close (Confirmed).
Last Earnings DateMar 7, 2024
Next Earnings DateMay 10, 2024
Ex-Dividend Date―
Financial Position
Onconetix as a current ratio of 0.05, with Debt / Equity ratio of 200.26%
Current Ratio0.05
Quick Ratio0.05
Debt to Market Cap5.39
Net Debt to EBITDA-0.15
Interest Coverage Ratio-40.13
Taxes
In the past 12 months, Onconetix has paid -1.05M in taxes.
Income Tax-1.05M
Effective Tax Rate0.02
Enterprise Valuation
Onconetix EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -1.00.
EV to Sales4.17
EV to EBITDA-0.18
EV to Free Cash Flow-1.00
EV to Operating Cash Flow-1.00
Balance Sheet
Onconetix has $1.58M in cash and marketable securities with $9.05M in debt, giving a net cash position of $7.47M billion.
Cash & Marketable Securities$1.58M
Total Debt$9.05M
Net Cash$7.47M
Net Cash Per Share$14.31
Tangible Book Value Per Share-$539.89
Margins
Gross margin is 47.37%, with operating margin of -2237.96%, and net profit margin of -2325.21%.
Gross Margin47.37%
Operating Margin-2237.96%
Pretax Margin-2366.62%
Net Profit Margin-2325.21%
EBITDA Margin-2281.88%
EBIT Margin-2310.85%
Analyst Forecast
The average price target for Onconetix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-97.16%